دوره 28، شماره 4 - ( 4-1396 )                   جلد 28 شماره 4 صفحات 33-39 | برگشت به فهرست نسخه ها

DOI: 10.18869/acadpub.umj.28.4.33

XML English Abstract Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Soleimani N, mohabbati mobarez A, khodamabadi N. Evaluation of proliferation and survival of spleen immune cells treated by Deacetylchitin nanoparticles on breast cancer mouse model. J Urmia Univ Med Sci. 2017; 28 (4) :33-39
URL: http://umj.umsu.ac.ir/article-1-3843-fa.html
Soleimani Neda، mohabbati mobarez ashraf، khodamabadi nima. Evaluation of proliferation and survival of spleen immune cells treated by Deacetylchitin nanoparticles on breast cancer mouse model. مجله پزشکی ارومیه. 1396; 28 (4) :33-39

URL: http://umj.umsu.ac.ir/article-1-3843-fa.html

Assistant Professor Shahid Beheshti University ، soleimani_neda86@yahoo.com
چکیده:   (347 مشاهده)

Background & Aims: Breast cancer is the most common carcinoma in women and one of the main causes of death in developed and developing countries. Today, compounds with immunolodulator properties can be replaced with routine drugs. One of them is Deacetylchitin. This study aimed to evaluate proliferation and survival of spleen immune cells treated by Deacetylchitin nanoparticles on breast cancer mouse model.

Materials & Methods: Deacetylchitin nanoparticles were prepared by ionic gelation method. Zeta Sizer device measured electrical charge of nanoparticles and their size was measured by DLS and SEM. The tumor was created within two weeks after injection to BALB/c mice and then different mice groups were treated with Deacetylchitin nanoparticles and controls with PBS. After three weeks, the mice were sacrificed. The proliferation and survival of spleen lymphocyte was evaluated by MTT.

Results: Deacetylchitin nanoparticles induce proliferation of spleen cells culture. Lymphocyte proliferation showed a significant increase in Deacetylchitin nanoparticles of treated group compared to control (p <0.05).

Conclusion: Our findings suggest that chitosan nanoparticles can stimulate the immune system and proliferate lymphocytes. This combination can be used as a medicinal supplement to stimulate the immune system to be effective in immunotherapy.

واژه‌های کلیدی: Immunotherapy، Deacetylchitin، Breast cancer
متن کامل [PDF 740 kb]   (83 دریافت)    
نوع مطالعه: پژوهشي(توصیفی- تحلیلی) | موضوع مقاله: فیزیولوژی
دریافت: ۱۳۹۵/۱۱/۲۴ | پذیرش: ۱۳۹۶/۱/۲۱ | انتشار: ۱۳۹۶/۴/۲۵

فهرست منابع
1. 1. Hashemzadeh S, Aligholipour Maleki R, Golzari SE. The incidence of breast cancer in northwest iran (2003 -2008). J Cardiovasc Thorac Res 2012;4(1):5–9.
2. 2. Duffy M. CA 15-3 and related mucins as circulating markers in breast cancer. Ann Clin Biochem 1999; 5: 579-86.
3. 3. Man Y, Stojadinovic A, Mason J. Tumor-Infiltrating Immune Cells Promoting Tumor Invasion and Metastasis: Existing Theories. J Cancer 2013; 4(1): 84–95.
4. 4. Kahlenborn C, Modugno F, Potter DM, Severs WB. Oral contraceptive use as a risk factor for premenopausal breast cancer: a meta-analysis. Mayo Clin Proc 2006; 81(10): 1290-302.
5. 5. Nelson HD, Zakher B, Cantor A, Fu R, Griffin J, O'Meara ES, et al. Risk factors for breast cancer for women aged 40 to 49 years: a systematic review and meta-analysis. Ann Intern Med 2012; 156(9): 635-48.
6. 6. Russo J, Rivera R, Russo IH. Influence of age and parity on the development of the human breast. Breast Cancer Res Treat 1992; 23(3): 211-8.
7. 7. Townsend CM, Jr. Treatment of breast cancer. Clin Symp 1997; 49(1):1-32.
8. 8. Ueda T, Volinia S, Okumura H, Shimizu M, Taccioli C, Rossi S, et al. Relation between microRNA expression and progression and prognosis of gastric cancer: a microRNA expression analysis. Lancet Oncol 2010;11:136–46.
9. 9. Stockler M, Wilcken NR, Ghersi D, Simes RJ. Systematic reviews of chemotherapy and endocrine therapy in metastatic breast cancer. Cancer Treat Rev 2000;26(3):151-68.
10. 10. Sieval A, Thanou M, Kotze A.F, Verhoef C.J, Brussee J, Junginger H.E. Preparation and NMR characterization of highly substituted N-trimethyl chitosan chloride. Carbohydrt Polym 1998; 36, 157–65.
11. 11. Grinberg O, Gedanken A, Patra CR, Patra S, Mukherjee P, Mukhopadhyay D. Sonochemically prepared BSA microspheres containing Gemcitabine, and their potential application in renal cancer therapeutics. Acta Biomater 2009;5(8):3031–7.
12. 12. Tan ML, Choong PF, Dass CR. Review: doxorubicin delivery systems based on chitosan for cancer therapy. J Pharm Pharmacol 2009; 61(2): 131-42.
13. 13. Saremi Sh, Atyabi F, Parinaz Akhlaghi S, Nasser Ostad S, Dinarvand R. Thiolated chitosan nanoparticles for enhancing oral absorption of docetaxel: preparation, in vitro and ex vivo evaluation. Int J Nanomedicine 2011; 6: 119–28.
14. 14. Soleimani N, Mobarez A, Jafari Olia M, Atyabi F. Synthesis, Characterization and Effect of the Antibacterial Activity of Chitosan Nanoparticles on Vancomycin- Resistant Enterococcus and Other Gram Negative or Gram Positive Bacteria. Int J Pure Appl Sci Tech 2015: 26(1): 14-23.
15. 15. Hosseinzadeh H, Atyabi F, Dinarvand R, Naser Ostad S. Chitosan–Pluronic nanoparticles as oral delivery of anticancer gemcitabine: preparation and in vitro study. Int J Nanomedicine 2012; 7: 1851–63.
16. 16. Soleimani N, Mohabati-Mobarez A, Atyabi F, Hasan-Saraf Z, Haghighi M. Preparation of chitosan nanoparticles carrying recombinant helicobacter pylori neutrophil-activating protein. J Mazandaran Univ Med Sci 2014; 23 (2) 23 (2):134-44.
17. 17. Daneshmandi S, Hajimoradi M, Soleimani N, Sattari M. Modulatory effect of Acetobacter xylinum cellulose on peritoneal macrophages. Immunopharmacol Immunotoxicol2011: 33 (1), 164-8.
18. 18. Yousofi A, Daneshmandi S, Soleimani N, Bagheri K, Karimi MH. Immunomodulatory effect of Parsley (Petroselinum crispum) essential oil on immune cells: mitogen-activated splenocytes and peritoneal macrophages. Immunopharmacol Immunotoxicol 2012: 34 (2), 303-8.
19. 19. Vila A and et al. Low molecular weight chitosan nanoparticles as new carriers for nasal vaccine delivery in mice. Eur J Pharm Biopharm 2004; 57: 123-31.
20. 20. Zhang H, Wu S, Tao Y, Zang L, Su Z. Preparation and characterization of water-soluble chitosan nanoparticles as protein delivery system. J Nanomaterials 2010;5:1–5.
21. 21. Potdar PD, Shetti AU. Evaluation of antimetastatic effect of chitosan nanoparticles on esophageal cancer associated fibroblasts. J Cancer Metasta Treat 2016;2:259-67.
22. 22. Solomon W, Leung Wenjuan G, Tae Hwan James C.K. Lai Effect of Chitosan and Nanoparticles on Cancer Cells Treated with Therapeutic Drugs: Comparison of Cell Survival, advance in nano biomechanics robot and energy research, the world congress, 2013.
23. 23. Wimardhani YS, Suniarti DF, Freisleben HJ, Wanandi SI, Siregar NC, Ikeda M-A. Chitosan exerts anticancer activity through induction of apoptosis and cell cycle arrest in oral cancer cells. J Oral Sci 2014;56(2):119–26.
24. 24. Rauw F, Gardin Y, Palya V, Anbari S, Gonze M, Lemaire S, et al. The positive adjuvant effect of chitosan on antigen-specific cell-mediated immunity after chickens vaccination with live Newcastle disease vaccine. Vet Immunol Immunopathol 2010;134(3–4):249–58.
25. 25. Bowman K, Leong KW. Chitosan nanoparticles for oral drug and gene delivery. Int J Nanomedicine 2006;1(2):117-28.
26. Gregory AE, Titball R, Williamson D. Vaccine delivery using nanoparticles. Front Cell Infect Microbiol 2013;3:13.

ارسال نظر درباره این مقاله : نام کاربری یا پست الکترونیک شما:
کد امنیتی را در کادر بنویسید

ارسال پیام به نویسنده مسئول

کلیه حقوق این وب سایت متعلق به مجله پزشکی ارومیه می باشد.

طراحی و برنامه نویسی : یکتاوب افزار شرق

© 2015 All Rights Reserved | URMIA MEDICAL JOURNAL

Designed & Developed by : Yektaweb